Owen O’Connor: Nouveau BioSciences have been chosen as finalists in “Galant Challenge” at the University of Virginia
Owen O’Connor, Founder and Chief Executive Officer at Nouveau Biosciences, recently shared on LinkedIn:
“Nouveau BioSciences is thrilled to have been chosen as one of the four finalists in this year’s ‘Galant Challenge’ at the University of Virginia. The Galant Challenge connects seed and early-stage ventures from the UVA community with potential investors.
Since launching in 2012, the annual pitch competition hosted by the McIntire School of Commerce’s Galant Center for Innovation and Entrepreneurship is one of the nation’s premier university startup events, with significant funding by investors each year.
The 2023 Challenge reached historic levels—entrepreneur teams who pitched raised more than $15 million to take their ventures to the next level.”
Read further.
Source: Owen A. O’Connor/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023